13F filer · CIK 1425738
Redmile Group, LLC
LARKSPUR, CA · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$1.5B
$-20.6M vs prior
Positions
39
New / sold out
4 / 0
Added / reduced
5 / 23
Turnover
6.7%
buys $100.2M · sells $445.6M
Top-10 weight
73.5%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | AGOMAB THERAPEUTICS NV | +2,577,676 | +1649.7% | +$33.5M |
| New | CLIMB BIO INC | +1,226,330 | – | +$16.0M |
| New | AURA BIOSCIENCES INC | +1,666,667 | – | +$11.8M |
| Added | SHATTUCK LABS INC | +1,352,309 | +24.4% | +$9.4M |
| New | ODYSSEY THERAPEUTICS INC | +425,000 | – | +$8.0M |
| Added | CELLDEX THERAPEUTICS INC NEW | +172,413 | +65.9% | +$6.4M |
| New | INSMED INC | +51,234 | – | +$5.5M |
| Added | BIOMARIN PHARMACEUTICAL INC | +91,310 | +52.5% | +$5.2M |
| Added | IDEAYA BIOSCIENCES INC | +119,085 | +22.9% | +$4.4M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | SCHOLAR ROCK HLDG CORP | -4,755,529 | -52.5% | $-261.6M |
| Reduced | NURIX THERAPEUTICS INC | -3,659,021 | -47.3% | $-88.8M |
| Reduced | ABSCI CORPORATION | -1,513,641 | -18.3% | $-17.5M |
| Reduced | KRYSTAL BIOTECH INC | -41,500 | -6.2% | $-15.4M |
| Reduced | ANNEXON INC | -2,679,891 | -18.4% | $-15.3M |
| Reduced | IMMUNOME INC | -647,295 | -11.6% | $-13.7M |
| Reduced | COGENT BIOSCIENCES INC | -184,715 | -26.8% | $-7.1M |
| Reduced | STOKE THERAPEUTICS INC | -218,200 | -5.2% | $-7.1M |
| Reduced | ADC THERAPEUTICS SA | -3,943,792 | -25.5% | $-4.2M |
| Reduced | BEAM THERAPEUTICS INC | -73,400 | -5.9% | $-2.5M |
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SCHOLAR ROCK HLDG CORPCOM | 4,311,092 | $237.1M | 15.92% |
| 2 | KRYSTAL BIOTECH INCCOM | 632,005 | $234.9M | 15.77% |
| 3 | STOKE THERAPEUTICS INCCOM | 3,945,920 | $129.1M | 8.67% |
| 4 | IMMUNOME INCCOM | 4,911,590 | $104.1M | 6.99% |
| 5 | NURIX THERAPEUTICS INCCOM | 4,073,787 | $98.8M | 6.64% |
| 6 | ABSCI CORPORATIONCOM | 6,739,675 | $78.1M | 5.24% |
| 7 | ANNEXON INCCOM | 11,869,877 | $67.8M | 4.55% |
| 8 | REGENXBIO INCCOM | 4,368,804 | $52.3M | 3.51% |
| 9 | SHATTUCK LABS INCCOM | 6,892,033 | $47.8M | 3.21% |
| 10 | NEUROGENE INCCOM | 1,412,199 | $44.4M | 2.98% |
29 more rows. Subscribe for $29/month to see every row, download the data and use the API.